{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:38:43Z","timestamp":1789756723753,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.blre.2025.101352","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:02:20Z","timestamp":1763636540000},"page":"101352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Adenovirus infection in adult allogeneic hematopoietic stem cell transplant recipients: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"75","author":[{"given":"Nadir","family":"Ullah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Muccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bartalucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Balletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sepulcri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Cerchiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Mikulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2025.101352_bb0005","first-page":"1","article-title":"Adenovirus infection in patients undergoing hematopoietic stem cell transplantation","author":"Friedland","year":"2024","journal-title":"Curr Treat Options Infect Dis"},{"issue":"25","key":"10.1016\/j.blre.2025.101352_bb0010","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1182\/blood-2010-04-259291","article-title":"How I treat adenovirus in hematopoietic stem cell transplant recipients","volume":"116","author":"Lindemans","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2025.101352_bb0015","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/TP.0000000000003988","article-title":"Adenovirus infection and transplantation","volume":"106","author":"Al-Heeti","year":"2022","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.blre.2025.101352_bb0020","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1007\/s00277-019-03755-2","article-title":"Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study","volume":"98","author":"Czy\u017cewski","year":"2019","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.blre.2025.101352_bb0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-0036-1584923","article-title":"Adenovirus: epidemiology, global spread of novel serotypes, and advances in treatment and prevention","volume":"37","author":"Lynch","year":"2016","journal-title":"Semin Respir Crit Care Med"},{"issue":"24","key":"10.1016\/j.blre.2025.101352_bb0030","first-page":"3571","article-title":"Adenovirus persistence, reactivation, and clinical management","volume":"593","author":"Lion","year":"2019"},{"issue":"6","key":"10.1016\/j.blre.2025.101352_bb0035","first-page":"555","article-title":"European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011)","volume":"14","author":"Matthes-Martin","year":"2012"},{"issue":"3","key":"10.1016\/j.blre.2025.101352_bb0040","volume":"28","author":"Hiwarkar","year":"2018"},{"issue":"3","key":"10.1016\/j.blre.2025.101352_bb0045","doi-asserted-by":"crossref","DOI":"10.1111\/petr.14750","article-title":"Approach for defining human adenovirus infection and disease for central review adjudication in clinical studies","volume":"28","author":"Fisher","year":"2024","journal-title":"Pediatr Transplant"},{"issue":"3","key":"10.1016\/j.blre.2025.101352_bb0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/ejh.13194","article-title":"Current practices in the management of adenovirus infection in allogeneic hematopoietic stem cell transplant recipients in Europe: the advance study","volume":"102","author":"Gonz\u00e1lez-Vicent","year":"2019","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.blre.2025.101352_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13283","article-title":"Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: multicenter survey of transplant centers in the United States","volume":"22","author":"Papanicolaou","year":"2020","journal-title":"Transpl Infect Dis"},{"issue":"8","key":"10.1016\/j.blre.2025.101352_bb0060","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s41409-018-0421-0","article-title":"A survey on incidence and management of adenovirus infection after allogeneic HSCT","volume":"54","author":"Cesaro","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.blre.2025.101352_bb0065","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/cid\/cis689","article-title":"Adenoviremia has limited clinical impact in the majority of patients following alemtuzumab-based allogeneic stem cell transplantation in adults","volume":"55","author":"Sive","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.blre.2025.101352_bb0070","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00005-014-0320-z","article-title":"Incidence of adenoviral DNAemia in polish adults undergoing allogeneic haematopoietic stem cell transplantation","volume":"63","author":"Rynans","year":"2015","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"2","key":"10.1016\/j.blre.2025.101352_bb0075","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14215","article-title":"Adenovirus infection in adult patients undergoing allogeneic hematopoietic stem cell transplant: incidence, clinical management, and outcome","volume":"26","author":"Balletto","year":"2024","journal-title":"Transpl Infect Dis"},{"issue":"11","key":"10.1016\/j.blre.2025.101352_bb0080","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/j.1469-0691.2011.03488.x","article-title":"Diagnostic value of quantitative PCR for adenovirus detection in stool samples as compared with antigen detection and cell culture in haematopoietic stem cell transplant recipients","volume":"17","author":"Jeulin","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.blre.2025.101352_bb0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jcv.2017.09.013","article-title":"Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir \u2013 case series and 10 year experience of management in an adult transplant cohort","volume":"96","author":"Ramsay","year":"2017","journal-title":"J Clin Virol"},{"issue":"11","key":"10.1016\/j.blre.2025.101352_bb0090","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1093\/jac\/dkab259","article-title":"Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study","volume":"76","author":"Stern","year":"2021","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.blre.2025.101352_bb0095","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbmt.2016.12.621","article-title":"Brincidofovir for asymptomatic adenovirus viremia in pediatric and adult allogeneic hematopoietic cell transplant recipients: a randomized placebo-controlled phase II trial","volume":"23","author":"Grimley","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2025.101352_bb0100","first-page":"38","article-title":"Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model","volume":"112","author":"Tollefson","year":"2014"},{"issue":"17","key":"10.1016\/j.blre.2025.101352_bb0105","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1182\/bloodadvances.2021004456","article-title":"Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted","volume":"5","author":"Rubinstein","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.blre.2025.101352_bb0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13045-017-0469-0","article-title":"Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I\/II multicenter clinical trial","volume":"10","author":"Qian","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"12","key":"10.1016\/j.blre.2025.101352_bb0115","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood-2014-06-573725","article-title":"Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT","volume":"125","author":"Feucht","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2025.101352_bb0120","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.blre.2025.101352_bb0125","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.bbmt.2018.12.753","article-title":"Incidence of adenovirus infection in hematopoietic stem cell transplantation recipients: findings from the advance study","volume":"25","author":"Sedl\u00e1\u010dek","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.blre.2025.101352_bb0130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"issue":"7109","key":"10.1016\/j.blre.2025.101352_bb0135","first-page":"629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997"},{"issue":"11","key":"10.1016\/j.blre.2025.101352_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15098","article-title":"High rate of adenovirus detection in gastrointestinal biopsies of symptomatic stem cell transplant recipients","volume":"37","author":"Pikkel-Geva","year":"2023","journal-title":"Clin Transplant"},{"issue":"9","key":"10.1016\/j.blre.2025.101352_bb0145","doi-asserted-by":"crossref","first-page":"619.e1","DOI":"10.1016\/j.jtct.2022.06.016","article-title":"Clinical and economic burden of multiple double-stranded DNA viral infections after allogeneic hematopoietic cell transplantation","volume":"28","author":"Hill","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.blre.2025.101352_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12885","article-title":"Prospective monitoring of adenovirus infection and type analysis after allogeneic hematopoietic cell transplantation: a single-center study in Korea","volume":"20","author":"Kang","year":"2018","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.blre.2025.101352_bb0155","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ebiom.2017.12.030","article-title":"Intestinal adenovirus shedding before allogeneic stem cell transplantation is a risk factor for invasive infection post-transplant","volume":"28","author":"Kosulin","year":"2018","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.blre.2025.101352_bb0160","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12823","article-title":"Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion","volume":"20","author":"Triplett","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.blre.2025.101352_bb0165","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jaci.2017.07.008","article-title":"T-cell receptor \u03b1\u03b2+ and CD19+ cell\u2013depleted haploidentical and mismatched hematopoietic stem cell transplantation in primary immune deficiency","volume":"141","author":"Shah","year":"2018","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.blre.2025.101352_bb0170","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.bbmt.2017.06.008","article-title":"Co-infections by double-stranded DNA viruses after ex vivo T cell\u2013depleted, CD34+ selected hematopoietic cell transplantation","volume":"23","author":"Huang","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.blre.2025.101352_bb0175","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12693","article-title":"Respiratory virus infection after allogeneic hematopoietic stem cell transplant in a tropical center: predictive value of the immunodeficiency scoring index","volume":"19","author":"Wang","year":"2017","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.blre.2025.101352_bb0180","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbmt.2015.08.019","article-title":"Adenovirus viremia in adult CD34+ selected hematopoietic cell transplant recipients: low incidence and high clinical impact","volume":"22","author":"Lee","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.blre.2025.101352_bb0185","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/jmv.24161","article-title":"Large-scale multiplex polymerase chain reaction assay for diagnosis of viral reactivations after allogeneic hematopoietic stem cell transplantation","volume":"87","author":"Inazawa","year":"2015","journal-title":"J Med Virol"},{"issue":"8","key":"10.1016\/j.blre.2025.101352_bb0190","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbmt.2014.04.004","article-title":"Viral respiratory infections diagnosed by multiplex PCR after allogeneic hematopoietic stem cell transplantation: long-term incidence and outcome","volume":"20","author":"Wolfromm","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.blre.2025.101352_bb0195","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bbmt.2012.10.014","article-title":"Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institution","volume":"19","author":"Lee","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.blre.2025.101352_bb0200","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1590\/0037-8682-1699-2013","article-title":"Human adenovirus detection among immunocompetent and immunocompromised patients presenting acute respiratory infection","volume":"46","author":"Watanabe","year":"2013","journal-title":"Rev Soc Bras Med Trop"},{"issue":"26","key":"10.1016\/j.blre.2025.101352_bb0205","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2025.101352_bb0210","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcv.2012.04.009","article-title":"Adenovirus infections in Bordeaux University hospital 2008-2010: clinical and virological features","volume":"54","author":"Berciaud","year":"2012","journal-title":"J Clin Virol"},{"issue":"10","key":"10.1016\/j.blre.2025.101352_bb0215","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.bbmt.2011.02.001","article-title":"Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin","volume":"17","author":"Sauter","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.blre.2025.101352_bb0220","first-page":"405","article-title":"Prevalence of viral infections and hemorrhagic cystitis in hematopoietic stem cell transplant recipients","volume":"9","author":"Shakiba","year":"2011","journal-title":"Exp Clin Transplant"},{"issue":"9","key":"10.1016\/j.blre.2025.101352_bb0225","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1128\/JCM.00976-10","article-title":"Comparison of in-house real-time quantitative PCR to the adenovirus R-gene kit for determination of adenovirus load in clinical samples","volume":"48","author":"Jeulin","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.blre.2025.101352_bb0230","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1016\/j.transproceed.2010.08.049","article-title":"Hematuria due to adenoviral infection in bone marrow transplant recipients","volume":"42","author":"Bil-Lula","year":"2010","journal-title":"Transplant Proc"},{"issue":"5","key":"10.1016\/j.blre.2025.101352_bb0235","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1399-3062.2010.00528.x","article-title":"Poor outcome of adenovirus infections in adult hematopoietic stem cell transplant patients with sustained adenovirus viremia","volume":"12","author":"Omar","year":"2010","journal-title":"Transpl Infect Dis"},{"issue":"12","key":"10.1016\/j.blre.2025.101352_bb0240","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00705-010-0802-1","article-title":"PCR diagnostics and monitoring of adenoviral infections in hematopoietic stem cell transplantation recipients","volume":"155","author":"Bil-Lula","year":"2010","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.blre.2025.101352_bb0245","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bcmd.2007.06.020","article-title":"T cell therapy of Epstein\u2013Barr virus and adenovirus infections after hemopoietic stem cell transplant","volume":"40","author":"Comoli","year":"2008","journal-title":"Blood Cells Mol Dis"},{"issue":"3","key":"10.1016\/j.blre.2025.101352_bb0250","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbmt.2003.11.001","article-title":"Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab","volume":"10","author":"Avivi","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.blre.2025.101352_bb0255","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1083-8791(03)00102-2","article-title":"Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival","volume":"9","author":"Bruno","year":"2003","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.blre.2025.101352_bb0260","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jcv.2011.06.005","article-title":"High lethality of human adenovirus disease in adult allogeneic stem cell transplant recipients with high adenoviral blood load","volume":"52","author":"Ganzenmueller","year":"2011","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.blre.2025.101352_bb0265","doi-asserted-by":"crossref","first-page":"233.e1","DOI":"10.1016\/j.jtct.2023.11.015","article-title":"Opportunistic infections in patients receiving post-transplantation cyclophosphamide: impact of haploidentical versus unrelated donor allograft","volume":"30","author":"Little","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"10.1016\/j.blre.2025.101352_bb0270","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/ajh.26723","article-title":"Adenovirus disease after hematopoietic cell transplantation: a Japanese transplant registry analysis","volume":"97","author":"Inamoto","year":"2022","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.blre.2025.101352_bb0275","doi-asserted-by":"crossref","first-page":"395.e1","DOI":"10.1016\/j.jtct.2022.04.020","article-title":"Haploidentical versus matched unrelated versus matched sibling donor hematopoietic cell transplantation with post-transplantation cyclophosphamide","volume":"28","author":"Mehta","year":"2022","journal-title":"Transplant Cell Ther"},{"issue":"2","key":"10.1016\/j.blre.2025.101352_bb0280","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/10428194.2021.1978088","article-title":"Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes","volume":"63","author":"Chaekal","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1016\/j.blre.2025.101352_bb0285","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14481","article-title":"Viral kinetics and outcomes of adenovirus viremia following allogeneic hematopoietic cell transplantation","volume":"35","author":"Chandorkar","year":"2021","journal-title":"Clin Transplant"},{"issue":"7","key":"10.1016\/j.blre.2025.101352_bb0290","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/infdis\/jiaa237","article-title":"Adenovirus viral kinetics and mortality in ex vivo T cell-depleted hematopoietic cell transplant recipients with adenovirus infection from a single center","volume":"222","author":"Lee","year":"2020","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.blre.2025.101352_bb0295","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.bbmt.2020.01.013","article-title":"Infections after allogenic transplant with post-transplant cyclophosphamide: impact of donor HLA matching","volume":"26","author":"Oltolini","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.blre.2025.101352_bb0300","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13626","article-title":"Clinical impact of multiple DNA virus infections in nondepleted haploidentical and unrelated allogeneic hematopoietic stem cell transplantation","volume":"23","author":"Kerbauy","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.blre.2025.101352_bb0305","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jcv.2017.05.019","article-title":"Impact of stem cell graft on early viral infections and immune reconstitution after allogeneic transplantation in adults","volume":"93","author":"Illiaquer","year":"2017","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.blre.2025.101352_bb0310","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/jmv.24579","article-title":"Adenovirus infection among allogeneic stem cell transplant recipients","volume":"89","author":"C\u00e9sar Pereira Santos","year":"2017","journal-title":"J Med Virol"},{"key":"10.1016\/j.blre.2025.101352_bb0315","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcv.2016.07.002","article-title":"Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Hubmann","year":"2016","journal-title":"J Clin Virol"},{"issue":"9","key":"10.1016\/j.blre.2025.101352_bb0320","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/bmt.2013.33","article-title":"Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience","volume":"48","author":"Yilmaz","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1016\/j.blre.2025.101352_bb0325","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00277-012-1440-3","article-title":"Incidence and treatment strategy for disseminated adenovirus disease after haploidentical stem cell transplantation","volume":"91","author":"Taniguchi","year":"2012","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.blre.2025.101352_bb0330","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/bmt.2010.86","article-title":"Evaluation of a surveillance strategy for early detection of adenovirus by PCR of peripheral blood in hematopoietic SCT recipients: incidence and outcome","volume":"46","author":"\u00d6hrmalm","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.blre.2025.101352_bb0335","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0609.2007.00821.x","article-title":"Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning","volume":"78","author":"Kalpoe","year":"2007","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1016\/j.blre.2025.101352_bb0340","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2002-02-0377","article-title":"Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery","volume":"100","author":"Chakrabarti","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.blre.2025.101352_bb0345","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1086\/319352","article-title":"Adenovirus infections in adult recipients of blood and marrow transplants","volume":"32","author":"La Rosa","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2025.101352_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101092","article-title":"Does PTCY increase the risk of infections?","volume":"62","author":"Mikulska","year":"2023","journal-title":"Blood Rev"},{"issue":"10","key":"10.1016\/j.blre.2025.101352_bb0355","doi-asserted-by":"crossref","first-page":"695.e1","DOI":"10.1016\/j.jtct.2022.07.021","article-title":"Post-transplantation cyclophosphamide versus tacrolimus and methotrexate graft-versus-host disease prophylaxis for HLA-matched donor transplantation","volume":"28","author":"Mehta","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.blre.2025.101352_bb0360","first-page":"1","article-title":"Adenovirus diseases: a systematic review and meta-analysis of 228 case reports","volume":"49","author":"Gu","year":"2021"},{"issue":"2","key":"10.1016\/j.blre.2025.101352_bb0365","first-page":"S89","article-title":"Preliminary results of a phase 2a clinical trial to evaluate safety, tolerability and antiviral activity of intravenous brincidofovir (BCV IV) in immunocompromised patients with Adenovirus infection","volume":"30","author":"Grimley","year":"2024"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X25000979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X25000979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T04:15:07Z","timestamp":1772511307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X25000979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":73,"alternative-id":["S0268960X25000979"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2025.101352","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenovirus infection in adult allogeneic hematopoietic stem cell transplant recipients: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2025.101352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101352"}}